Clinical Trial Update: Renal Transplantation and Raltegravir in HIV-Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating raltegravir in HIV-infected patients undergoing renal transplantation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)

Snippet

Sponsor: ANRS, Emerging Infectious Diseases | Conditions: HIV-1 Infection, Chronic Renal Insufficiency | Phase 3 | Status: COMPLETED